Beyond Psoriasis: Why Biologics Are Reshaping Disease-Specific Dermatology Introduction Biologics have transformed the therapeutic landscape of chronic inflammatory dermatoses, demonstrating remarkable efficacy and safety profiles in conditions previously challenging to manage. These targeted immunomodulators have revolutionized treatment approaches for moderate-to-severe psoriasis, hidradenitis suppurativa,
Tag: IL-17 IL-23 breakthroughs
